Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jungryun Kim

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|October 23, 2025
Dexamethasone-Appended Activatable Prodrug Overcoming Multidrug ResistanceJungryun Kim, Chong Hu, Paramesh Jangili, et al.
Journal of the American Chemical Society|March 2, 2026
Tetrazine-Mediated Bioorthogonally Activated Therapeutic (TBAT) PlatformsJungryun Kim, Snehasish Debnath, Eunji Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 28, 2023
THQ-Xanthene: An Emerging Strategy to Create Next-Generation NIR-I/II FluorophoresZhiqiang Mao, Hyeonji Rha, Jungryun Kim, et al.
Angewandte Chemie (International Ed. in English)|November 8, 2024
Metabolic Acidity/H<sub>2</sub>O<sub>2</sub> Dual-Cascade-Activatable Molecular Imaging Platform Toward Metastatic Breast Tumor MalignancyKun Dou, Jiao Lu, Yanlong Xing, et al.
Chemical Society Reviews|June 20, 2023
One-dimensional nanomaterials for cancer therapy and diagnosisJinwoo Shin, Nayeon Kang, Byungkook Kim, et al.
Chemical Society Reviews|September 7, 2022
Cancer therapeutics based on diverse energy sourcesSubin Son, Jungryun Kim, Jaewon Kim, et al.
Biomaterials|December 10, 2023
Endogenous CO imaging in bacterial pneumonia with a NIR fluorescent probeBeitong Zhu, Xuejian Xing, Jungryun Kim, et al.
Chemical Reviews|August 21, 2025
Site-Specific Transformable Nanostructures for Cancer Therapy and DiagnosisJungryun Kim, Yubin Lee, Yuri Kim, et al.
Journal of the American Chemical Society|November 30, 2024
Bioorthogonal Activation of Deep Red Photoredox Catalysis Inducing PyroptosisJungryun Kim, Yunjie Xu, Jong Hyeon Lim, et al.
Bioactive Materials|October 3, 2022
Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applicationsNem Singh, Jungryun Kim, Jaewon Kim, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|October 23, 2025
Dexamethasone-Appended Activatable Prodrug Overcoming Multidrug ResistanceJungryun Kim, Chong Hu, Paramesh Jangili, et al.
Journal of the American Chemical Society|March 2, 2026
Tetrazine-Mediated Bioorthogonally Activated Therapeutic (TBAT) PlatformsJungryun Kim, Snehasish Debnath, Eunji Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 28, 2023
THQ-Xanthene: An Emerging Strategy to Create Next-Generation NIR-I/II FluorophoresZhiqiang Mao, Hyeonji Rha, Jungryun Kim, et al.
Angewandte Chemie (International Ed. in English)|November 8, 2024
Metabolic Acidity/H<sub>2</sub>O<sub>2</sub> Dual-Cascade-Activatable Molecular Imaging Platform Toward Metastatic Breast Tumor MalignancyKun Dou, Jiao Lu, Yanlong Xing, et al.
Chemical Society Reviews|June 20, 2023
One-dimensional nanomaterials for cancer therapy and diagnosisJinwoo Shin, Nayeon Kang, Byungkook Kim, et al.
Chemical Society Reviews|September 7, 2022
Cancer therapeutics based on diverse energy sourcesSubin Son, Jungryun Kim, Jaewon Kim, et al.
Biomaterials|December 10, 2023
Endogenous CO imaging in bacterial pneumonia with a NIR fluorescent probeBeitong Zhu, Xuejian Xing, Jungryun Kim, et al.
Chemical Reviews|August 21, 2025
Site-Specific Transformable Nanostructures for Cancer Therapy and DiagnosisJungryun Kim, Yubin Lee, Yuri Kim, et al.
Journal of the American Chemical Society|November 30, 2024
Bioorthogonal Activation of Deep Red Photoredox Catalysis Inducing PyroptosisJungryun Kim, Yunjie Xu, Jong Hyeon Lim, et al.
Bioactive Materials|October 3, 2022
Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applicationsNem Singh, Jungryun Kim, Jaewon Kim, et al.
Pageof 2